Innovo Therapeutics Inc. – Trademark Portfolio
Entity Type: 03
Innovo Therapeutics Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include MOTIFULL, TRINOGENIX, INNOVO THERAPEUTICS, and DEEPZEMA AI-AUGMENTED DRUG DISCOVERY.
#507, 38, Mapo-daero,
Mapo-gu Seoul 04174
Showing of trademarks Trademarks
Trademark Classifications
Innovo Therapeutics Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Innovo Therapeutics Inc. have?
Innovo Therapeutics Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.
What trademark classes does Innovo Therapeutics Inc. file in?
Innovo Therapeutics Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 42 (Computer & Scientific). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Innovo Therapeutics Inc.'s most well-known trademarks?
Innovo Therapeutics Inc.'s registered trademark portfolio includes well-known marks such as MOTIFULL, TRINOGENIX, INNOVO THERAPEUTICS, and DEEPZEMA AI-AUGMENTED DRUG DISCOVERY. These are among 4 currently registered trademarks in the portfolio.
What is Innovo Therapeutics Inc.'s trademark registration success rate?
Innovo Therapeutics Inc. has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.